Effect of Monensin on Cow Health and Milk Production in Early Lactation

Authors

  • T. F. Duffield Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • K. E. Leslie Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • D. Sandals Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • K. Lissemore Department of Population Medicine, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • B. McBride Department of Animal & Poultry Science, University of Guelph, Guelph, Ontario, Canada N1G 2W1
  • J. H. Lumsden Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1

DOI:

https://doi.org/10.21423/aabppro19975877

Keywords:

monensin, periparturient disease, milk production

Abstract

Dry cows and springing heifers from twenty-five farms near Guelph, Ontario, Canada were enrolled in a large double blinded and randomized clinical trial designed to evaluate the impact of monensin on periparturient disease and milk production. A total of 503 cows were given monensin controlled release capsules and 507 animals were administered placebo capsules three weeks prior to expected calving date.

Downloads

Published

1997-09-18

Issue

Section

Research Summaries - Dairy I & II

Most read articles by the same author(s)

1 2 3 4 5 > >>